A compilation of hundreds of U.S. nuclear sites and activities that were to be declared to the International Atomic Energy Agency by the United States was transmitted to Congress last month by President Obama.
“The enclosed draft declaration lists each site, location, facility, and activity I intend to declare to the IAEA, and provides a detailed description of such sites, locations, facilities, and activities, and the provisions of the U.S.-IAEA Additional Protocol under which they would be declared,” the President wrote. “Each site, location, facility, and activity would be declared in order to meet the obligations of the United States of America with respect to these provisions.”
“The IAEA classification of the enclosed declaration is ‘Highly Confidential Safeguards Sensitive’,” the President noted in his May 5, 2009 transmittal letter, “however, the United States regards this information as ‘Sensitive but Unclassified’.”
But sensitive or not, the draft declaration was promptly published by the Government Printing Office. See “The List of Sites, Locations, Facilities, and Activities Declared to the International Atomic Energy Agency,” message from the President of the United States, May 6, 2009 (267 pages, 13 MB PDF file).
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.